Security Snapshot

HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE) Institutional Ownership

CUSIP: 405024100

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

329

Shares (Excl. Options)

49.62MFull value: 49,624,007 · shares · 30 Jun 2026

Price

$75.00

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common stock, $0.01 par value per share
Symbol
HAE on NYSE
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
49,624,007
Latest holder snapshot 5 signals
Total 13F value
$3,715,119,791
Portfolio coverage rank
0%
Share change
+2,046,039
Value change
+$182,038,507
Number of holders
329
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
45,420,621
SEC-reported price per share
$119.47
Insider filing price
$119.47
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • HAE - HAEMONETICS CORP - Common stock, $0.01 par value per share is tracked under CUSIP 405024100.
  • 329 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 324 to 329 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $2.68BFull value: $2,681,997,623 · USD · 31 Mar 2026
    to
    $3.72BFull value: $3,715,119,791 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 329 institutions filings for Q2 2026.

Open SEC evidence

Security key

405024100

13F reference period

Q2 2026

13F holders

329

13D/G owners

6

CIK / CUSIP context first

Open Q2 2026 holders HAE full holder history HAEMONETICS CORP SEC filings HAEMONETICS CORP company facts HAEMONETICS CORP insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
HAE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD PORTFOLIO MANAGEMENT LLC 5.6% $146,544,172 2,600,145 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.3% $137,846,246 2,445,817 Vanguard Capital Management 31 Mar 2026
AQR CAPITAL MANAGEMENT LLC 5% -25% $169,986,675 -$67,246,125 2,266,489 -28% AQR Capital Management, LLC 30 Jun 2026
WELLINGTON MANAGEMENT GROUP LLP 4.6% -16% $165,537,761 -$36,448,193 2,203,351 -18% Wellington Management Group LLP 30 Jun 2025
T. Rowe Price Investment Management, Inc. 4.4% $135,949,632 2,195,569 T. Rowe Price Investment Management, Inc. 31 Mar 2025
Capital Research Global Investors 3.1% $97,667,840 1,577,323 Capital Research Global Investors 31 Mar 2025
As of 30 Jun 2026, 329 institutional investors reported holding
49.62MFull value: 49,624,007 · shares · 30 Jun 2026
shares of HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE). This represents 109% of the company’s total
45.42MFull value: 45,420,621 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
82%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 5,909,258 +5.1% 0.01% $443,194,350
NEUBERGER BERMAN GROUP LLC 9.2% 4,179,443 +17% 0.21% $313,473,399
VANGUARD PORTFOLIO MANAGEMENT LLC 5.6% 2,546,394 -0.5% 0.01% $190,979,550
AQR CAPITAL MANAGEMENT LLC 5% 2,266,489 -32% 0.06% $165,023,065
ARIEL INVESTMENTS, LLC 4.5% 2,060,966 1.5% $154,572,450
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 2,059,578 -1.5% 0% $154,468,350
STATE STREET CORP 4% 1,818,186 +2.6% 0% $136,363,950
DIMENSIONAL FUND ADVISORS LP 3.5% 1,585,222 +20% 0.02% $118,892,744
CITADEL ADVISORS LLC 3.3% 1,510,120 +485% 0.07% $113,259,000
GEODE CAPITAL MANAGEMENT, LLC 2.8% 1,287,240 +5.6% 0.01% $96,559,855
River Road Asset Management, LLC 2.8% 1,285,602 -3.2% 1.1% $96,420,150
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2.5% 1,155,351 -16% 0.04% $86,651,325
T. Rowe Price Investment Management, Inc. 2.4% 1,101,371 +84% 0.05% $82,603,000
GOLDMAN SACHS GROUP INC 2.3% 1,046,019 +9.8% 0.01% $78,451,463
UBS Group AG 2.2% 983,378 +87% 0.01% $73,753,350
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 1.8% 830,925 -1.2% 0.31% $62,319,375
ROYAL BANK OF CANADA 1.7% 780,248 -9.1% 0.01% $58,518,000
Allspring Global Investments Holdings, LLC 1.7% 765,120 -14% 0.09% $57,269,232
PRICE T ROWE ASSOCIATES INC /MD/ 1.4% 636,797 +52% 0% $47,761,000
DEUTSCHE BANK AG\ 1.4% 631,663 +76% 0.01% $47,374,725
NORTHERN TRUST CORP 1.4% 631,542 +9% 0.01% $47,365,650
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 591,423 +3.4% 0.01% $44,356,725
Boston Trust Walden Corp 1.3% 585,148 +17% 0.33% $43,886,100
MILLENNIUM MANAGEMENT LLC 1.3% 570,413 +5730% 0.03% $42,780,975
Holocene Advisors, LP 1.2% 550,195 +12067% 0.09% $41,264,625

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,761,492 $185,678,169 -$15,656,357 $105.30 68
2026 Q2 49,624,007 $3,715,119,791 +$182,038,507 $75.00 329
2026 Q1 47,621,777 $2,681,997,623 -$232,314,744 $56.36 324
2025 Q4 50,859,989 $4,075,910,711 +$58,180,392 $80.15 329
2025 Q3 51,319,539 $2,500,166,518 -$232,706,500 $48.74 298
2025 Q2 54,253,774 $4,048,407,950 +$51,089,014 $74.61 297
2025 Q1 53,724,229 $3,412,895,600 -$212,763,194 $63.55 313
2024 Q4 56,558,011 $4,415,683,452 +$40,389,204 $78.08 305
2024 Q3 55,858,330 $4,486,624,929 -$21,003,128 $80.38 303
2024 Q2 55,851,715 $4,621,294,419 +$385,980,667 $82.73 315
2024 Q1 51,176,074 $4,367,618,453 +$50,781,270 $85.35 296
2023 Q4 50,568,886 $4,325,205,912 -$20,996,057 $85.51 294
2023 Q3 50,792,206 $4,551,407,114 +$20,351,169 $89.58 294
2023 Q2 50,542,703 $4,303,570,562 +$14,249,115 $85.14 288
2023 Q1 50,384,868 $4,169,004,070 +$9,612,280 $82.75 294
2022 Q4 50,382,562 $3,963,254,277 -$107,357,997 $78.65 287
2022 Q3 51,775,808 $3,833,648,345 -$28,085,090 $74.03 260
2022 Q2 52,080,593 $3,394,785,256 +$49,689,135 $65.18 229
2022 Q1 51,567,377 $3,257,869,910 +$120,748,445 $63.22 225
2021 Q4 50,084,803 $2,655,680,021 -$87,203,336 $53.04 240
2021 Q3 50,697,310 $3,576,779,438 +$7,330,940 $70.59 239
2021 Q2 50,672,122 $3,375,443,272 -$52,557,812 $66.64 249
2021 Q1 49,961,531 $5,549,106,460 -$22,300,347 $111.01 288
2020 Q4 49,701,181 $5,902,338,582 +$13,637,273 $118.75 278
2020 Q3 49,419,749 $4,312,359,704 -$6,823,951 $87.25 261
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .